Document Detail

A case of secondary erythromelalgia with perivascular and intramural mucin.
MedLine Citation:
PMID:  25302988     Owner:  NLM     Status:  Publisher    
We present a 49-year-old man with type I erythromelalgia, demonstrating a newly reported histological feature of striking perivascular mucin. There is a single previously reported case in the literature describing these histological features. This patient had a comorbid history of primary myelofibrosis diagnosed 2 years prior to his presentation.
Tristan Blake; Rohan Mortimore; Kathryn De Ambrosis
Related Documents :
20336918 - Imported acute and isolated glottic paracoccidioidomycosis.
11339588 - Heroin withdrawal as a possible cause of acute concomitant esotropia in adults.
22507028 - Simultaneously diagnosed pulmonary thromboembolism and hemopericardium in a man with th...
17490198 - Ns08 are chronic subdural haematomas more common on the left than on the right?
24719798 - The management of spontaneous otogenic csf leaks: a presentation of cases and review of...
22522358 - Idiopathic bilateral auricular petrification.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-10
Journal Detail:
Title:  The Australasian journal of dermatology     Volume:  -     ISSN:  1440-0960     ISO Abbreviation:  Australas. J. Dermatol.     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-10-10     Completed Date:  -     Revised Date:  2014-10-11    
Medline Journal Info:
Nlm Unique ID:  0135232     Medline TA:  Australas J Dermatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2014 The Australasian College of Dermatologists.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Salicylic Acid Alleviates the Adverse Effects of Salt Stress in Torreya grandis cv. Merrillii Seedli...
Next Document:  Structure-activity relationships of a novel capsid targeted inhibitor of HIV-1 replication.